UnitedHealth reported adjusted earnings per share of $2.11 for Q4 2025, a sharp decline from $6.81 a year earlier but narrowly ahead of the consensus forecast of $2.10. Consolidated revenues climbed 12% year-over-year to $113.215 billion, slightly below Wall Street’s $113.817 billion estimate. The disparity between strong top-line growth and compressed earnings was driven by higher medical costs and one-off restructuring charges, which weighed on UnitedHealthcare’s underwriting margins and Optum’s operating profitability during the quarter.

Management reiterated full-year adjusted EPS guidance of at least $17.75 per share, in line with the Street’s $17.74 consensus, and introduced a GAAP earnings outlook of $17.10. The company forecast 2026 revenues of more than $439 billion, below the consensus near $454.6 billion, reflecting a strategic emphasis on restoring core margins rather than aggressive membership expansion. Executives outlined plans to deliver roughly $1 billion in annualized OPEX savings through AI-driven automation and tighter network management, targeting a return to a 5.5% EBIT margin at UnitedHealthcare.

Investor concerns centered on the Centers for Medicare & Medicaid Services’ proposed flat Medicare Advantage rate for 2027, which would cap premium revenue growth and strain underwriting profitability at the nation’s largest MA insurer. Despite the 20% one-day market-cap loss following the CMS rate announcement, UnitedHealth’s diversified Optum services division and robust cash flow generation should cushion near-term headwinds. Analysts argue these policy uncertainties are largely priced into current valuations, supporting a constructive long-term view for investors focused on margin stabilization and sustainable free cash flow yield.